Barrie J. Carter
Direktor/Vorstandsmitglied bei American Society of Gene Therapy
Profil
Barrie J.
Carter is currently the Director at the American Society of Gene Therapy and a Member-Advisory Committee at the University of Washington.
Previously, he held positions as the Director at Opus Bio, Inc., Chief Scientific Officer & Executive VP at AmpliPhi Biosciences Corp.
from 1992 to 2008, Vice President-Vector Biology at BioMarin Pharmaceutical, Inc. from 2013 to 2018, Principal at the National Institutes of Health in 1992, Principal at the National Institute of Diabetes & Digestive & Kidney Diseases from 1982 to 1992, and was a Member-Advisory Board at Keystone Symposia.
Dr. Carter obtained his undergraduate degree from the University of Otago in 1996 and his doctorate degree from the same university in 1969.
Aktive Positionen von Barrie J. Carter
| Unternehmen | Position | Beginn |
|---|---|---|
| American Society of Gene Therapy | Direktor/Vorstandsmitglied | - |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | 01.01.2000 |
Ehemalige bekannte Positionen von Barrie J. Carter
| Unternehmen | Position | Ende |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01.12.2018 |
AmpliPhi Biosciences Corp.
 AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Technik-/Wissenschafts-/F&E-Leiter | 06.11.2008 |
| National Institute of Diabetes & Digestive & Kidney Diseases | Corporate Officer/Principal | 01.01.1992 |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 01.01.1992 |
Keystone Symposia
 Keystone Symposia Miscellaneous Commercial ServicesCommercial Services Keystone Symposia operates as a catalyst for the advancement of biomedical and life sciences by connecting scientists within and across disciplines at conferences and workshops. The company was founded by C. Fred Fox in 1972 and is headquartered in Silverthorne, CO. | Direktor/Vorstandsmitglied | 31.10.2011 |
Ausbildung von Barrie J. Carter
| University of Otago | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Health Technology |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
| National Institute of Diabetes & Digestive & Kidney Diseases | Government |
Opus Bio, Inc.
 Opus Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Opus Bio, Inc. develops and manufactures lentiviral gene delivery technologies. Its Lentiviral vectors (LV), technology platform is used for delivery of genetic sequence information into cells to reprogram function and to treat epithelial cancers. The company was founded by Boro Dropulic in 2004 and is headquartered in Baltimore, MD. | Commercial Services |
Keystone Symposia
Keystone Symposia Miscellaneous Commercial ServicesCommercial Services Keystone Symposia operates as a catalyst for the advancement of biomedical and life sciences by connecting scientists within and across disciplines at conferences and workshops. The company was founded by C. Fred Fox in 1972 and is headquartered in Silverthorne, CO. | Commercial Services |
| American Society of Gene Therapy |
